The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trialChristopher G. Davey, Michael Berk, Andrew M. Chanen et al.|The Lancet Psychiatry|2019Cited by 109
Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirinMichael Berk, Christopher G. Davey, Mohammadreza Mohebbi et al.|BMC Medicine|2020Cited by 70
Pituitary volume and early treatment response in drug-naïve first-episode psychosis patientsBelinda Garner, Patrick D. McGorry, M. McConchie et al.|Schizophrenia Research|2009Cited by 35
Youth Depression Alleviation‐Augmentation with an anti‐inflammatory agent (<scp>YoDA‐A</scp>): protocol and rationale for a placebo‐controlled randomized trial of rosuvastatin and aspirinAmelia L. Quinn, Michael Berk, Olivia Dean et al.|Early Intervention in Psychiatry|2015Cited by 20
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trialChristopher G. Davey, Patrick D. McGorry, Andrew M. Chanen et al.|Trials|2014Cited by 12